The project launched on 1st Oct 2020 in Singapore. The objective of the Fund is to achieve long-term capital growth and regular income. Derive the majority of their revenue and earnings from Singapore and which focus on trading and stockpiling of wild ginseng grown in the People’s Republic of China and certified by competent authorities in the People’s Republic of China.

Ginseng has been used in traditional Chinese medicine for centuries. This slow-growing, short plant with fleshy roots can be classified three ways, depending on how long it is grown: fresh, white or red. There are many types of this herb, but the most popular are American ginseng and Asian ginseng.

American and Asian ginseng vary in their concentration of active compounds and effects on the body. It is believed that American ginseng works as a relaxing agent, whereas the Asian variety has an invigorating effect.

The Fund may also invest in money market instruments and other highly liquid instruments if desired. The investment program of the Fund is speculative and may entail substantial risks. Market risks are inherent in all investments to varying degrees. There can be no assurance that the investment objective of the Fund will be achieved. In fact, certain investment practices described above can, in some circumstances, potentially increase the adverse impact on the Fund’s investment portfolio.

Let’s get started on a project now!